A carregar...
Personalized Therapy for Non-Small Cell Lung Cancer: Which Drug for Which Patient?
The elucidation of the molecular alterations in non-small cell lung cancer (NSCLC) and the development of molecularly targeted agents have permanently shifted NSCLC therapy to a personalized approach. In the metastatic setting, the addition of the anti–vascular endothelial growth factor monoclonal a...
Na minha lista:
| Publicado no: | Semin Thorac Cardiovasc Surg |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2011
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4836182/ https://ncbi.nlm.nih.gov/pubmed/22443647 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1053/j.semtcvs.2012.01.001 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|